Moderna's founder urges immediate AI regulation

Billionaire Noubar Afeyan, founder of Moderna, has urged immediate regulation of artificial intelligence agents being developed by tech firms. Afeyan warned that delaying regulation could lead to repeating past mistakes seen in the pharmaceutical industry. He emphasized the need for proactive measures to prevent potential harm. Afeyan's comments come as AI technology continues to advance rapidly, with companies racing to deploy new capabilities. His call for regulation highlights growing concerns about the ethical and safety implications of AI development. The urgency of regulation is underscored by Afeyan's comparison to the drug industry, where past failures led to stricter oversight. He argued that waiting for a crisis to act is too late. His remarks align with increasing calls for transparency and accountability in AI development. As the industry moves forward, the need for a regulatory framework is becoming more apparent. Afeyan's position highlights the importance of addressing ethical concerns before they escalate into major issues.